CAM
NVO

Cypress Asset Management’s Novo Nordisk NVO Stock Holding History

Cypress Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,625
Closed -$201K – 107
2025
Q3 		$201K Sell
3,625
-13,628
-79% -$798K 0.05% 105
2025
Q2 		$1.19M Sell
17,253
-1,142
-6% -$77.7K 0.29% 61
2025
Q1 		$1.28M Buy
18,395
+323
+2% +$26.7K 0.34% 58
2024
Q4 		$1.62M Sell
18,072
-927
-5% -$100K 0.4% 56
2024
Q3 		$2.26M Buy
18,999
+933
+5% +$124K 0.56% 48
2024
Q2 		$2.68M Buy
18,066
+150
+0.8% +$19.9K 0.69% 42
2024
Q1 		$2.39M Buy
17,916
+221
+1% +$26.3K 0.65% 44
2023
Q4 		$1.83M Buy
17,695
+935
+6% +$92.5K 0.55% 50
2023
Q3 		$1.52M Buy
16,760
+2,070
+14% +$182K 0.51% 53
2023
Q2 		$1.22M Buy
14,690
+9,000
+158% +$735K 0.39% 65
2023
Q1 		$453K Buy
5,690
+50
+0.9% +$3.55K 0.16% 99
2022
Q4 		$385K Hold
5,640
– – 0.14% 100
2022
Q3 		$281K Buy
+5,640
New +$302K 0.11% 112
2018
Q1 		– Sell
-11,904
Closed -$319K – 188
2017
Q4 		$319K Sell
11,904
-1,950
-14% -$49.6K 0.07% 152
2017
Q3 		$334K Buy
+13,854
New +$313K 0.07% 151
2016
Q3 		– Sell
-7,854
Closed -$211K – 208
2016
Q2 		$211K Hold
7,854
– – 0.04% 192
2016
Q1 		$213K Hold
7,854
– – 0.04% 185
2015
Q4 		$228K Sell
7,854
-200
-2% -$5.54K 0.05% 178
2015
Q3 		$218K Hold
8,054
– – 0.05% 179
2015
Q2 		$221K Hold
8,054
– – 0.04% 187
2015
Q1 		$215K Buy
+8,054
New +$185K 0.04% 186

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cypress Asset Management's NVO Position: Q4 2025 in Review

Cypress Asset Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,625 shares — an estimated $201K sold.

Cypress Asset Management first reported a position in NVO in Q1 2015 and held it in 21 quarters. The position peaked at $2.68M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Cypress Asset Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Cypress Asset Management sold 3,625 Novo Nordisk shares in Q4 2025, an estimated $201K.
  • Cypress Asset Management first reported a position in Novo Nordisk in Q1 2015 and held it in 21 quarters.
  • Cypress Asset Management's Novo Nordisk position peaked at $2.68M in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.